Patents Assigned to PGEN Therapeutics, Inc.
  • HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME
    Publication number: 20210024586
    Abstract: Provided herein are engineered human papilloma virus (HPV) molecular vaccine constructs. Vaccine constructs can also include ligand-inducible engineered gene switch systems for modulating expression of heterologous genes, such as a cytokines, in host cells.
    Type: Application
    Filed: March 6, 2019
    Publication date: January 28, 2021
    Applicants: Precigen, Inc., PGEN Therapeutics, Inc.
    Inventors: Douglas E. BROUGH, Cheryl G. BOLINGER, Ramya YARLAGADDA, Vinodhbabu KURELLA, Ponraj PRABAKARAN, Simon METENOU, Kuan-Fu DING
  • HEPATITIS B VACCINES AND USES OF THE SAME
    Publication number: 20210015911
    Abstract: Provided herein are engineered hepatitis B virus (HBV) molecular vaccine constructs. Vaccine constructs can also include ligand-inducible engineered gene switch systems for modulating expression of heterologous genes, such as a cytokines, in host cells.
    Type: Application
    Filed: March 6, 2019
    Publication date: January 21, 2021
    Applicants: Precigen, Inc., PGEN Therapeutics, Inc.
    Inventors: Douglas E. BROUGH, Cheryl G. BOLINGER, Ramya YARLAGADDA, Vinodhbabu KURELLA, Ponraj PRABAKARAN, Simon METENOU, Kuan-Fu DING